Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

GENT: Disclosure of shareholding

Gentian Diagnostics
Viola AS, a wholly-owned subsidiary of Rasmussengruppen AS, sold 50,000 shares
in Gentian Diagnostics ASA (the "Company") on 23 May 2025 with settlement on 27
May 2025.

As a result of the transaction, companies wholly-owned by Rasmussengruppen AS
decreased their consolidated holding of shares in the Company from 793,421 to
743,421 shares, equal to a decrease from approximately 5.14% to approximately
4.82% of the votes and shares in the Company. The shares are held by Viola AS
(208,421 shares), Portia AS (300,000 shares) and Cressida AS (235,000 shares).

The above mentioned companies have no other rights to shares issued by the
Company.

This announcement is made in accordance with Section 4-2 of the Norwegian
Securities Trading Act.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.